Sahyadri Hospital, Bopodi

Name :

Sahyadri Hospital, Bopodi

Address  :

S.N.10A / 3 A, Ahead of Khadki Railway station,
Next to Bopodi Police Chowky Bopodi,

Town  :

Pune

State  :

Maharashtra

Country  :

INDIA

Post Code:

411 020

Phone  :

020 66319800

Web URL  :

Sahyadri Hospital Bopodi
Specialization
  • Anaesthesiology
  • Blood Bank
  • Cardiology
  • Cardiothoracic Surgeon
  • Colour Doppler
  • Cosmetic Surgery
  • CT Scanning
  • Dentistry
  • Dermatology
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Gynaecology
  • Internal Medicine
  • MRI Scanning
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Pain Management
  • Pathology Lab
  • Physiotherapy
  • Pulmonology
  • Urology
  • Vascular Surgeon
Facilities

Total Number Of Beds : 65

Ambulance Contact Number : 88888 22222

Speciality Type :

Multi Speciality :

  • Surgical General
  • Gynaecology
  • Dental
  • Orthopedic

Other Facilities

  • Pathology
  • X-Ray
  • CT/MRI
  • Physiotherapy

Advance Facility

  • Blood Bank

Description

About Us
Sahyadri Hospital Bopodi Sahyadri Hospital Bopodi started functioning in June 2009

It is the first hospital started as a PPP Public Private Partnership within the city of Pune With the launch of this hospital Sahyadri extends its quality health care to the middle class residents of Bopodi and surrounding areas

It has a bed strength of 104 beds in a well lit pleasant warm amp well furnished ambience with infrastructure to handle all types of emergency amp routine patients
Hinduja Hospital gets HACCP certification

Mumbai The 60year old Hinduja hospital here has received the HACCP Hazard Analysis Critical Control Point certification from a Netherlandbased agency The HACCP methodology is a structured and preventive approach to food safety that optimises efforts to provide the consumer with safe food a release said The hospital put to test its food servic... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More